Cargando…
Cardiovascular Pharmacogenomics: Current Status and Future Directions—Report of a National Heart, Lung, and Blood Institute Working Group
Autores principales: | Musunuru, Kiran, Roden, Dan M., Boineau, Robin, Bristow, Michael R., McCaffrey, Timothy A., Newton-Cheh, Christopher, Paltoo, Dina N., Rosenberg, Yves, Wohlgemuth, Jay G., Zineh, Issam, Hasan, Ahmed A. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487365/ https://www.ncbi.nlm.nih.gov/pubmed/23130127 http://dx.doi.org/10.1161/JAHA.111.000554 |
Ejemplares similares
-
Ethical and public policy challenges for pharmacogenomics
por: Gershon, Elliot S., et al.
Publicado: (2014) -
Quantitative Systems Pharmacology: A Regulatory Perspective on Translation
por: Zineh, Issam
Publicado: (2019) -
The clinical pharmacogeneticist: An emerging regulatory scientist at the US Food and Drug Administration
por: Zineh, Issam, et al.
Publicado: (2010) -
Detection and Management of Geographic Disparities in the TOPCAT Trial: Lessons Learned and Derivative Recommendations
por: Bristow, Michael R., et al.
Publicado: (2016) -
Heart Failure Strategically Focused Research Network: Summary of Results and Future Directions
por: Felker, G.Michael, et al.
Publicado: (2022)